Mid Ohio Oncology/Hematology Mark H. Zangmeister Center — Columbus, Ohio

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center has participated in 1 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Ohio Oncology/Hematology Mark H. Zangmeister Center?

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Ohio Oncology/Hematology Mark H. Zangmeister Center conducted?

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center has 1 clinical trials on record. Their work covers PI3K Pathway Activated Tumors.

Is Mid Ohio Oncology/Hematology Mark H. Zangmeister Center accredited by Crixeo Health?

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid Ohio Oncology/Hematology Mark H. Zangmeister Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.